Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta (Nasdaq: AZTA) announced its participation in the upcoming 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The company's management team will attend the virtual event scheduled for Tuesday, August 12, 2025. This conference provides an opportunity for investors and analysts to engage with Azenta's leadership through one-on-one meetings.
Azenta (Nasdaq: AZTA) ha annunciato la sua partecipazione al prossimo 10° Annuale Needham Virtual MedTech & Diagnostics 1x1 Conference. Il team di gestione dell'azienda parteciperà all'evento virtuale previsto per martedì 12 agosto 2025. Questa conferenza offre un'opportunità a investitori e analisti di interagire con i dirigenti di Azenta tramite incontri individuali.
Azenta (Nasdaq: AZTA) anunció su participación en la próxima 10ª Conferencia Anual Virtual Needham MedTech & Diagnostics 1x1. El equipo directivo de la compañía asistirá al evento virtual programado para el martes 12 de agosto de 2025. Esta conferencia brinda una oportunidad para que inversores y analistas se reúnan personalmente con el liderazgo de Azenta.
Azenta (나스닥: AZTA)는 다가오는 제10회 연례 니드햄 가상 메드테크 및 진단 1대1 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 8월 12일 화요일에 예정된 가상 행사에 참석할 예정입니다. 이 컨퍼런스는 투자자와 애널리스트가 Azenta 경영진과 일대일로 소통할 수 있는 기회를 제공합니다.
Azenta (Nasdaq : AZTA) a annoncé sa participation à la prochaine 10e conférence annuelle virtuelle Needham MedTech & Diagnostics 1x1. L'équipe de direction de l'entreprise assistera à l'événement virtuel prévu pour le mardi 12 août 2025. Cette conférence offre aux investisseurs et analystes une occasion d'échanger en tête-à-tête avec les dirigeants d'Azenta.
Azenta (Nasdaq: AZTA) gab seine Teilnahme an der bevorstehenden 10. jährlichen Needham Virtual MedTech & Diagnostics 1x1 Konferenz bekannt. Das Management-Team des Unternehmens wird an der für Dienstag, den 12. August 2025 geplanten virtuellen Veranstaltung teilnehmen. Diese Konferenz bietet Investoren und Analysten die Möglichkeit, sich in Einzelgesprächen mit der Führung von Azenta auszutauschen.
- None.
- None.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-10th-annual-needham-virtual-medtech--diagnostics-1x1-conference-302517735.html
SOURCE Azenta
FAQ
When is Azenta (AZTA) participating in the Needham Virtual MedTech Conference?
What type of conference is Azenta (AZTA) attending in August 2025?
Who will represent Azenta (AZTA) at the Needham Conference?
Is the Needham MedTech Conference that Azenta is attending virtual or in-person?
